Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Candesartan cilexetil is a prescription angiotensin II receptor blocker. It is approved for hypertension in adults and children age 1 to under 17 and for heart failure in adults with reduced left ventricular systolic function. Tablets come in 4 mg, 8 mg, 16 mg, and 32 mg strengths.
read more about candesartan ...Candesartan cilexetil is converted to candesartan during absorption. Candesartan selectively blocks angiotensin II from binding to AT1 receptors in vascular smooth muscle and the adrenal gland. This reduces vasoconstriction and aldosterone-related effects, lowering blood pressure and reducing strain on the heart.
Candesartan is approved for hypertension in adults and children age 1 to under 17. It is also used for New York Heart Association class II to IV heart failure in adults with left ventricular ejection fraction of 40 percent or less to reduce cardiovascular death and heart failure hospitalization.
Adults with hypertension commonly start at 16 mg once daily, with a total daily range of 8 mg to 32 mg. Adult heart failure treatment starts at 4 mg once daily and targets 32 mg once daily through dose increases about every two weeks as tolerated. Pediatric hypertension dosing is based on age and body weight.
Candesartan carries a boxed warning for fetal toxicity and is stopped when pregnancy is detected. Other concerns include low blood pressure, worsening kidney function, and high potassium. Kidney function and serum potassium are checked in patients at increased risk. Aliskiren use with candesartan is contraindicated in patients with diabetes.
Yes. Candesartan is an angiotensin II receptor blocker that selectively blocks AT1 receptors.
Yes. Current labeling includes hypertension treatment in children age 1 to under 17.
The labeled target dose is 32 mg once daily, reached through gradual dose increases as tolerated.
Yes. The boxed warning covers fetal toxicity from medicines that act directly on the renin-angiotensin system.
ATACAND (candesartan cilexetil) tablet. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94a59260-d2b6-464a-b5b9-bbc599e57e10. Date Accessed September 21, 2026.
Candesartan. MedlinePlus. https://www.medlineplus.gov/druginfo/meds/a601033.html. Date Accessed September 21, 2026.
Candesartan. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK519501/. Date Accessed September 21, 2026.
DailyMed - CANDESARTAN CILEXETIL tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26df3269-3682-4ce0-be81-8c029254b5a8. Date Accessed September 21, 2026.
FDALabel - Candesartan Cilexetil. https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/386476. Date Accessed September 21, 2026.